International Reports

Sr. No. Name Description Files
1 World Drug Report 2022 Booklet 1 The World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability and this booklet is an executive summary of the WDR 2022 View
2 World Drug Report 2022 Booklet 2 This booklet contains an overview of the global demand for and supply of drugs. View
3 World Drug Report 2022 Booklet 3 This booklet has dual focus : opioids and cannabis. It provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opiates and synthetic opioids and the availability of pharmaceutical opioids for medical consumption. View
4 World Drug Report 2022 Booklet 4 This Booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS. View
5 World Drug Report 2022 Booklet 5 This booklet contains a deep dive into the nexus between drugs and the environment. The aim is to provide a comprehensive overview of the current state of research into the direct and indirect effects of illicit crop cultivation, drug manufacture and drug policy responses on the environment, in order to assist Member States in anticipating and addressing environmental challenges and in mitigating risks. View
6 World Drug Report 2021 Booklet 1 The World Drug Report 2021 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special focus on the impact of the COVID-19 pandemic, at assisting Member States in anticipating and addressing challenges that may arise in the near future. The Booklet 1 of the WDR 2021 summarizes the four subsequent booklets by reviewing their key findings and highlighting their policy implications. View
7 World Drug Report 2021 Booklet 2 The Booklet 2 of the WDR 2021 contains an overview of the global demand for and supply of drugs. It provides the latest estimates of and trends in drug use and looks at several cross-cutting issues related to the world drug problem. Among the issues examined are the extent of drug use and its health impact, including trends seen among people with drug use disorders, drug treatment demand, the harms resulting from NPS use, and HIV and hepatitis among people who inject drugs. The booklet also features a projection of the impact of population growth on drug use by 2030. On drug supply, the booklet provides an overview of the extent of illicit crop cultivation and trends in drug production and trafficking, including of NPS, at the global level. In addition, it reviews the latest evidence regarding the supply of drugs and other substances through drug markets on the Internet. It includes a chapter dedicated to the sale on the clear web of a number of synthetic substances destined for drug markets, and another on trafficking in drugs and NPS on the dark web. View
8 World Drug Report 2021 Booklet 3 The Booklet 3 of the WDR 2021 contains an analysis of the global market for cannabis, starting with a review of cannabis supply, including trends in the cultivation of and trafficking in cannabis herb and cannabis resin at the global level and in the various regions. It contains the latest estimates of and trends in cannabis use, including an analysis of changes over time in cannabis use and risk perceptions. The booklet also includes an overview of the latest developments in measures regulating the non-medical use of cannabis in Canada, Uruguay and some jurisdictions in the United States of America. With respect to opioids, the booklet discusses the overlaps between the various opioids, mostly in terms of demand dynamics. It also contains the latest estimates of and trends in opioid use at the global and regional levels, including an update on the availability of pharmaceutical opioids for medical consumption. That is followed by an overview of the latest estimates of and trends in the supply of opiates, from the cultivation of opium poppy and production of opium to trafficking trends and routes, on the basis of seizures made in the sub-regions in which opiates are produced and along the routes to the main opiate markets. The booklet concludes with a review of the supply of other opioids, in particular the trafficking trends and routes for fentanyls and tramadol both at the global level and in the sub-regions most affected. View
9 World Drug Report 2021 Booklet 4 The Booklet 4 of the WDR 2021 contains an analysis of the global market for cocaine, starting with a review of cocaine supply, including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. It also contains an overview of the latest estimates of and trends in cocaine use in different markets. With respect to ATS, the booklet reviews the latest trends in the supply of and demand for methamphetamine, amphetamine and “ecstasy”. It provides up-to-date information on the manufacture of each of these drugs, based on information on dismantled laboratories and seizures of precursor chemicals, and an overview of trafficking in them at the global level, with a particular focus on the regions and sub-regions most affected. The booklet also contains the latest estimates of and information on the trends in the use of amphetamines and “ecstasy” at the regional and global levels. View
10 World Drug Report 2021 Booklet 5 The Booklet 5 of the WDR 2021 contains an early assessment of the impact of the COVID-19 pandemic on drug markets, as the situation continues to evolve and more data become available. The aim is to paint a comprehensive picture of the measurable effects and potential impact of the COVID-19 crisis to assist Member States in anticipating and addressing challenges that may arise in the near future. The booklet contains an analysis of how the pandemic has affected drug production, manufacture and trafficking, according to region and drug type. This is followed by an analysis of the most recent trends and patterns in drug trafficking and the distribution of drugs at the retail level, including on the clear web and the dark web. The booklet also contains an analysis of how the COVID-19 pandemic and the measures to contain it have affected drug use and patterns of drug use, possible health consequences for drug users and how the provision of treatment and services to people who use drugs has been affected; a number of innovations in this area, which stem from the reaction to the pandemic, are described. The booklet concludes with an overview of the potential for long-term changes to drug markets as a result of the pandemic. View
11 World Drug Report 2020 Booklet 1 The Booklet 1 of the WDR 2020 provides a summary of the five subsequent booklets by reviewing their key findings and highlighting their policy implications. View
12 World Drug Report 2020 Booklet 2 The Booklet 2 of the WDR 2020 focuses on drug demand and contains a global overview of the extent of and trends in drug use, including drug use disorders, and its health consequences. View
13 World Drug Report 2020 Booklet 3 The Booklet 3 of the WDR 2020 deals with drug supply and presents the latest estimates and trends regarding the production of and trafficking in opiates, cocaine, amphetamine-type stimulants and cannabis. View
14 World Drug Report 2020 Booklet 4 The Booklet 4 of the WDR 2020 addresses a number of cross-cutting issues, including the macrodynamics that are driving the expansion and increasing complexity of the drug markets, and describes some of the rapidly evolving drug-related concerns: the latest, multifaceted global opioid crisis; rapid market changes; the market for new psychoactive substances; the use of the darknet for supplying drugs; and developments in jurisdictions that have measures allowing the non-medical use of cannabis. View
15 World Drug Report 2020 Booklet 5 The Booklet 5 of the WDR 2020 looks at the association between socioeconomic characteristics and drug use disorders, including at the macro-, community and individual levels, with a special focus on population subgroups that may be impacted differently by drug use and drug use disorders. View
16 World Drug Report 2020 Booklet 6 The Booklet 6 of the WDR 2020 addresses a number of other drug policy issues that all form part of the international debate on the drug problem but on which in-depth evidence is scarce, including access to controlled medicines, international cooperation on drug matters, alternative development in drug cultivation areas, and the nexus between drugs and crime. View
17 World Drug Report 2019 Booklet 1 The Booklet 1 of the WDR 2019 provides a summary of the four subsequent booklets by reviewing their key findings and highlighting policy implications based on their conclusions. View
18 World Drug Report 2019 Booklet 2 The Booklet 2 of the WDR 2019 contains a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs. View
19 World Drug Report 2019 Booklet 3 The Booklet 3 of the WDR 2019 looks at recent trends in the market for depressants (including opioids, sedatives, tranquillizers and hypnotics). View
20 World Drug Report 2019 Booklet 4 The Booklet 4 of the WDR 2019 deals with recent trends in the market for stimulants (including cocaine, amphetamine-type stimulants and new psychoactive substances). View
21 World Drug Report 2019 Booklet 5 The Booklet 5 of the WDR 2019 contains a review of recent trends in the market for cannabis and for hallucinogens. The section on cannabis also includes a review of the latest developments in the jurisdictions that have adopted measures allowing the non-medical use of cannabis. View
22 World Drug Report 2018 Booklet 1 The Booklet 1 of the WDR 2018 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. View
23 World Drug Report 2018 Booklet 2 The Booklet 2 of the WDR 2018 provides a global overview of the latest estimates of and trends in the supply, use and health consequences of drugs. View
24 World Drug Report 2018 Booklet 3 The Booklet 3 of the WDR 2018 examines current estimates of and trends in the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis), reviews the latest developments in cannabis policies and provides an analysis of the global synthetic drugs market, including new psychoactive substances. View
25 World Drug Report 2018 Booklet 4 The Booklet 4 of the WDR 2018 looks at the extent of drug use across age groups, particularly among young and older people, by reviewing the risks and vulnerabilities to drug use in young people, the health and social consequences they experience and their role in drug supply, as well as highlighting issues related to the health care needs of older people who use drugs. View
26 World Drug Report 2018 Booklet 5 The Booklet 5 of the WDR 2018 focuses on the specific issues related to drug use among women, including the social and health consequences of drug use and access to treatment by women with drug use disorders; it also discusses the role played by women in the drug supply chain. View
27 World Drug Report 2017 Booklet 1 The Booklet 1 of the WDR 2017 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. View
28 World Drug Report 2017 Booklet 1 The Booklet 1 of the WDR 2017 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. View
29 World Drug Report 2017 Booklet 2 The Booklet 2 of WDR 2017 deals with the supply, use and health consequences of drugs. View
30 World Drug Report 2017 Booklet 3 The Booklet 3 of the WDR 2017 focuses on the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis) and on the impact of new cannabis policies. View
31 World Drug Report 2017 Booklet 3 The Booklet 3 of the WDR 2017 focuses on the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis) and on the impact of new cannabis policies. View
32 World Drug Report 2017 Booklet 4 The Booklet 4 of WDR 2017 provides an extended analysis of the global synthetic drugs market and contains the bulk of the analysis for the triennial global synthetic drugs assessment View
33 World Drug Report 2017 Booklet 5 The Booklet 5 of WDR 2017 is titled : THE DRUG PROBLEM AND ORGANIZED CRIME, ILLICIT FINANCIAL FLOWS, CORRUPTION AND TERRORISM. It contains a discussion on the nexus between the drug problem, organized crime, illicit financial flows, corruption and terrorism. View
34 World Drug Report 2016 The World Drug Report 2016 is published in the wake of the landmark moment in global drug policy, the special session of the General Assembly on the world drug problem. Chapter I provides a global overview of the supply of and demand for opiates, cocaine, cannabis, amphetamine-type stimulants (ATS) and new psychoactive substances (NPS), as well as their impact on health. It also reviews the scientific evidence on polydrug use, treatment demand for cannabis and developments since the legalization of cannabis for recreational use in some parts of the world. Chapter II focuses on the mechanisms of the interaction between the world drug problem and all aspects of sustainable development through the lens of the Sustainable Development Goals. View
35 World Drug Report 2015 The World Drug Report presents a comprehensive annual overview of the latest developments in the world's illicit drug markets by focusing on the production, trafficking and consumption of the main types of illicit drugs, along with the related health consequences of those drugs. Chapter 1 of the World Drug Report 2015 not only provides a global overview of the supply of and demand for opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances, as well as their impact on health, but also provides a review of the scientific evidence on approaches to preventing drug use and addresses general principles for effective responses to treatment for drug use. Chapter 2 examines how alternative development, within the broader context of the development agenda, is aimed at breaking the vicious cycle of illicit crop cultivation by providing farmers with alternative livelihoods. View
36 INCB Annual Report 2011 Prior to the adoption of the 1912 International Opium Convention, the world was experiencing an abysmal situation with regard to drugs. In most countries, trade in drugs was not regulated and substance abuse was widespread. International Narcotics Control Board has published this Annual Report 2011. View
37 INCB Annual Report 2012 Each year, the International Narcotics Control Board (INCB) reports on the functioning of the international drug control system and developments in international drug control. Based on its findings, the Board makes recommendations to Governments and regional and international organizations to improve various aspects of drug control. International Narcotics Control Board has published this Annual Report 2012. View
38 INCB Annual Report 2013 The annual report of the International Narcotics Control Board (INCB) for 2013 marks a particular milestone: the 45th annual report of the Board since it was established in 1968 in accordance with the Single Convention on Narcotic Drugs of 1961. International Narcotics Control Board has published this Annual Report 2013. View
39 INCB Annual Report 2014 In facing the world drug problem, all countries find their destinies intertwined. For over a century, the international community has recognized that this problem is one that cannot be addressed effectively if it is not addressed collectively. The International Narcotics Control Board has published this Annual Report 2014. View
40 INCB Annual Report 2015 There is a global debate taking place on “the right way in drug policy”. The International Narcotics Control Board (INCB) will participate in this debate, given its mandate to monitor implementation of and compliance with the three international drug control conventions. International Narcotics Control Board has published this Annual Report 2015. View
41 INCB Annual Report 2016 INCB notes that, in the outcome document, Member States underscored the role of the three international drug control treaties as the basis for international cooperation, ensuring the availability of narcotic drugs and psychotropic substances for medical and scientific purposes, preventing illicit drug crop cultivation and production and addressing drug trafficking and abuse. International Narcotics Control Board has published this Annual Report 2016. View
42 INCB Annual Report 2017 Each year, the complexity of the world drug situation increases. The International Narcotics Control Board (INCB) is tasked with monitoring States’ implementation of the international drug control treaties and supporting Governments in ensuring the availability of narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion and abuse. International Narcotics Control Board has published this Annual Report 2017. View
43 INCB Annual Report 2018 The publication of the report of the International Narcotics Control Board (INCB) for 2018 marks the fiftieth anniversary of the establishment of the Board, pursuant to the Single Convention on Narcotic Drugs of 1961. International Narcotics Control Board has published this Annual Report 2018. View
44 INCB Annual Report 2019 The thematic chapter of the INCB annual report for 2019 focuses on improving prevention and treatment services for young people. The year 2019 marked the thirtieth anniversary of the Convention on the Rights of the Child. International Narcotics Control Board has published this Annual Report 2019. View
45 INCB Annual Report 2020 The year 2020 has been challenging like no other in recent history. The coronavirus disease (COVID-19) pandemic has had a devastating societal and economic impact, claiming many human lives, disrupting the social fabric and family lives, and causing further suffering, as patients with other health conditions could not access health services, including for mental health conditions. International Narcotics Control Board has published this Annual Report 2020. View
46 INCB Annual Report 2021 2021 was overshadowed by the coronavirus disease (COVID-19) pandemic, which continued to have a grave impact on the global community, causing immense suffering to individuals, placing a considerable burden upon health systems and slowing progress towards achieving the Sustainable Development Goals. International Narcotics Control Board has published this Annual Report 2021. View

All rights reserved / Disclaimer / Website Policy